Relmada Therapeutics’ $75 Million At-The-Market Offering

Ambrogio Visconti

Sichenzia Ross Ference LLP represented Relmada Therapeutics in the offering. Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a clinical stage company developing therapies for depression and central nervous…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now